Abstract
Patients with severe COVID-19 seem to evolve with a compromised antiviral response and hyperinflammation. Neutrophils are critical players in COVID-19. IL-17A plays a major role in protection again...
All Related Versions
Funding Information
  • Novartis Brazil
  • CNPq (312688/2017-2, 439119/2018-9)
  • MEC/CAPES (14/2020 − 23072.211119/2020-10)
  • FINEP (0494/20 01.20.0026.00)
  • The National Science and Technology Programs (465425/2014-3)
  • MCTI/CNPq/CAPES/FAPS

This publication has 38 references indexed in Scilit: